The Company will showcase its portfolio of novel, in-office women’s reproductive health solutions at booth #524 at the ACOG Clinical and Scientific Meeting, taking place May 1–3, 2026 at the Walter E.
Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1 -m AML who have no satisfactory alternative treatment options, ...
Utah’s experiment with AI-generated prescriptions won’t be the last. It raises urgent regulatory questions that needs answers ...
Counseling, by its very nature, is value-laden, and the process and results are greatly influenced by both the therapist’s ...
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple ...
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit observed across key subgroups, including patients with high ...
James Stewart starred as a small-town lawyer in a 1959 film based on a real-life court case that became one of the best trial ...
That is what emerges from a closer examination of adoption access for same-sex couples across different countries. There is ...
MONEY FOR HIS FAMILY. THEY SAY THAT THERE IS STRENGTH IN NUMBERS, AND LOOKING AT THIS CROWD, I CAN SEE JUST HOW STRONG WE ARE. THOUSANDS OF PEOPLE RALLYING AT THE STATE CAPITOL TODAY. THE HANDS OFF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results